SWS
AXSM icon

SYSTM Wealth Solutions’s Axsome Therapeutics AXSM Stock Holding History

SYSTM Wealth Solutions’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16
Closed -$1.28K – 688
2024
Q1 		$1.28K Hold
16
– – ﹤0.01% 931
2023
Q4 		$1.27K Buy
+16
New +$1.07K ﹤0.01% 978

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SYSTM Wealth Solutions's AXSM Position: Q2 2024 in Review

SYSTM Wealth Solutions sold out of Axsome Therapeutics (AXSM) in Q2 2024, closing a stake of 16 shares — an estimated $1.28K sold.

SYSTM Wealth Solutions first reported a position in AXSM in Q4 2023 and held it in 2 quarters. The position peaked at $1.28K in Q1 2024. 257 funds tracked by Wall St. Rank hold AXSM as of Q2 2024.

  • SYSTM Wealth Solutions reported no remaining Axsome Therapeutics position as of Q2 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 16 Axsome Therapeutics shares in Q2 2024, an estimated $1.28K.
  • SYSTM Wealth Solutions first reported a position in Axsome Therapeutics in Q4 2023 and held it in 2 quarters.
  • SYSTM Wealth Solutions's Axsome Therapeutics position peaked at $1.28K in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q2 2024, filed 12 Aug 2024.